129 related articles for article (PubMed ID: 17929232)
21. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
[TBL] [Abstract][Full Text] [Related]
23. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: what role in clinical practice?
Carter WB; Sarfati MR; Fox KA; Patton DD
Am Surg; 1997 Apr; 63(4):317-21. PubMed ID: 9124749
[TBL] [Abstract][Full Text] [Related]
24. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
[TBL] [Abstract][Full Text] [Related]
25. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
26. Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy.
Axelrod D; Sisson JC; Cho K; Miskulin J; Gauger PG
Arch Surg; 2003 Nov; 138(11):1214-8. PubMed ID: 14609869
[TBL] [Abstract][Full Text] [Related]
27. An analysis of sestamibi-positive versus -negative patients with primary hyperparathyroidism.
Parel RJ; Bolton JS; Fuhrman GM
Am Surg; 2001 Nov; 67(11):1101-4. PubMed ID: 11730230
[TBL] [Abstract][Full Text] [Related]
28. Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients.
Jones JM; Russell CF; Ferguson WR; Laird JD
Clin Radiol; 2001 Jul; 56(7):556-9. PubMed ID: 11446753
[TBL] [Abstract][Full Text] [Related]
29. The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.
Glynn N; Lynn N; Donagh C; Crowley RK; Smith D; Thompson CJ; Hill AD; Keeling F; Agha A
Ir J Med Sci; 2011 Mar; 180(1):191-4. PubMed ID: 21076888
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
31. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
32. Localization of parathyroid adenomas by (99m)Tc-sestamibi scanning: upper neck versus lower neck lesions.
Rodríguez-Carranza S; Cáceres M; Aguilar-Salinas CA; Gómez-Pérez FJ; Herrera MF; Pantoja JP; Rull JA
Endocr Pract; 2004; 10(6):472-7. PubMed ID: 16033718
[TBL] [Abstract][Full Text] [Related]
33. Treatment with oral biphosphonates can increase the sensitivity of sestamibi radionuclide imaging in patients with primary hyperparathyroidism.
Makras P; Kaltsas GA; Athanasoulis T; Papadogias D; Zografos GN; Kontogeorgos G; Borboli N; Piaditis G
Int J Clin Pharmacol Res; 2005; 25(1):19-28. PubMed ID: 15864874
[TBL] [Abstract][Full Text] [Related]
34. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
[TBL] [Abstract][Full Text] [Related]
35. Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism.
Swanson TW; Chan SK; Jones SJ; Bugis S; Irvine R; Belzberg A; Levine D; Wiseman SM
Am J Surg; 2010 May; 199(5):614-20. PubMed ID: 20466104
[TBL] [Abstract][Full Text] [Related]
36. Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship?
Piñero A; Rodríguez JM; Martínez-Barba E; Canteras M; Stiges-Serra A; Parrilla P
Surgery; 2003 Jul; 134(1):41-4. PubMed ID: 12874581
[TBL] [Abstract][Full Text] [Related]
37. Role of microvascular density in nonlocalizing parathyroid sestamibi scans.
Peters G; Kulbersh B; Mantle B; Bell W; Grizzle W; Rosenthal E
Laryngoscope; 2007 Dec; 117(12):2163-8. PubMed ID: 17921899
[TBL] [Abstract][Full Text] [Related]
38. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism.
Erbil Y; Kapran Y; Işsever H; Barbaros U; Adalet I; Dizdaroğlu F; Bozbora A; Ozarmağan S; Tezelman S
Am J Surg; 2008 Jan; 195(1):34-9. PubMed ID: 18082541
[TBL] [Abstract][Full Text] [Related]
39. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy.
Chiu B; Sturgeon C; Angelos P
Surgery; 2006 Sep; 140(3):418-22. PubMed ID: 16934604
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of the preoperative sestamibi scan in intraoperative localization of parathyroid adenomas: a case study.
George EF; Komisar A; Scharf SC; Ferracci A; Blaugrund S
Laryngoscope; 1998 May; 108(5):627-9. PubMed ID: 9591536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
